CancerFax
CLINICAL TRIALS

EXPANDED ACCESS
PROGRAMS

Expanded access programmes occupy the space between trial completion and commercial approval for patients who cannot wait for the approval timeline. They exist more often than patients realise -- finding them requires actively looking.

Upload Medical ReportsSpeak to Our Team

analyticsAt a Glance

  • check_circleExpanded access (compassionate use) allows patients to receive unapproved drugs outside a trial
  • check_circleAvailable when no comparable alternative therapy exists and the drug is in late-stage development
  • check_circleRequires approval from the manufacturer, the treating physician, and the regulatory authority
  • check_circleCancerFax can help identify expanded access programmes and guide the application process
Reviewed by: CancerFax Medical Team, Oncology & Haematology SpecialistsLast reviewed: April 16, 20268 min read

The Expanded Access Landscape

  • FDA-Authorised Expanded Access (US)

    Listed on ClinicalTrials.gov under study type Expanded Access. The listing includes eligibility criteria, the contact pathway, and whether new patients are being accepted. Search alongside clinical trial listings by drug name or cancer type.

  • Named-Patient and Early Access Programmes (International)

    The equivalent pathways in Europe, Australia, Canada, and elsewhere operate under different regulatory frameworks but serve the same purpose. Contact the manufacturer medical affairs department in the relevant country for current programme status.

  • Pre-Approval Access (PAA) Programmes

    Some manufacturers establish formal access programmes specifically for the period between pivotal trial completion and full regulatory approval. These are time-limited -- they close when the drug receives approval and becomes commercially available.

Frequently Asked Questions

    Related Pages in This Pillar

    How CancerFax Helps

    CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

    description
    Medical Record Review

    We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

    verified_user
    Eligibility Coordination

    We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

    hub
    Hospital Communication

    We support appointment coordination, document submission, translation, and direct communication with international departments.

    flight
    Travel & Admission Support

    For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

    explore
    Treatment & Trial Navigation

    If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

    support_agent
    End-to-end Coordination

    From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

    Send Medical ReportsSpeak With CancerFax

    CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

    Questions About Expanded Access for an Investigational Cancer Drug?

    CancerFax searches for expanded access programmes and compassionate use pathways relevant to your specific alteration and drug of interest.

    Upload Medical ReportsTalk to Our Team

    This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.